Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2023 Oct 26;3(10):e0002137. doi: 10.1371/journal.pgph.0002137

Impact of COVID-19 on health-related quality of life in the general population: A systematic review and meta-analysis

Desire Aime Nshimirimana 1,2,3,*, Donald Kokonya 4, Jesse Gitaka 1, Bernard Wesonga 4, Japheth Nzioki Mativo 5, Jean Marie Vianey Rukanikigitero 6
Editor: Anil Gumber7
PMCID: PMC10602258  PMID: 37883383

Abstract

The World Health Organization declared coronavirus disease of 2019 as an epidemic and public health emergency of international concern on January 30th, 2020. Different factors during a pandemic can contribute to low quality of life in the general population. Quality of life is considered multidimensional and subjective and is assessed by using patient reported outcome measures. The aim and objective of this review is to assess the impact of coronavirus disease of 2019 and associated factors on the Quality of Life in the general population. This review was conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. A protocol was registered in the international Prospective Register of Systematic Reviews database(CRD42021269897). A comprehensive electronic search in PubMed, EBSCO Host Research Databases, MEDLINE and Google scholar search engine was conducted. A total number of 1,7000,074 articles were identified from electronic search. 25 full text articles were retained for qualitative synthesis and seventeen articles for quantitative analysis. Seven main quality of life scales were used to assess the quality of life of the general population; World Health Organization Quality of Life-bref, EuroQuality of Life-Five dimensions, Short Form, European Quality of Life Survey, coronavirus disease of 2019 Quality of Life, General Health Questionnaire12 and My Life Today Questionnaire. The mean World Health Organization Quality of Life-brief was found to be 53.38% 95% confidence interval [38.50–68.27] and EuroQuality of Life-Five dimensions was 0.89 95% confidence interval [0.69–1.07]. Several factors have been linked to the Coronavirus disease of 2019 such as sociodemographic factors, peoples living with chronic diseases, confinement and financial constraints. This review confirms that the Coronavirus disease of 2019 pandemic affected the quality of life of the general population worldwide. Several factors such as sociodemographic, peoples living with chronic diseases, confinement and financial constraints affected the quality of life.

Background

The World Health Organization (WHO) declared coronavirus disease of 2019 (COVID-19) an epidemic and public health emergency of international concern on January 30th, 2020. The virus is known to have originated from Wuhan City, Hubei Province, China in December 2019. COVID-19 drew global attention due to rapid increase in the numbers reported both in China and internationally within shortest period [1]. By February 20th, 2020, the number of contaminated COVID-19 cases in China reached a cumulative total of 75,465 cases and it had already spread to more than 25 countries among them Germany, Italy, France, Japan, Malaysia, Singapore, South Korea, Spain, Thailand, Vietnam, the United Arab Emirates, the United Kingdom (UK), the United States of America (USA) and Africa [2]. According to WHO (2021), a total of 190,597,409 confirmed cases of COVID-19, among them 4,093,145 deaths and only 3,430,051,539 vaccine doses have already been administered worldwide by 18th July 2021. Psychological conditions such as depression, anxiety and stress can contribute to the deterioration of quality of life (QoL) of populations. A Spanish study assessed the impact of COVID-19 on mental health and find that the most prevalent mental disorders were anxiety, sleep and affective disorders as well as depression with a considerable increase in suicidal behavior among women and men over 70 years old [3]. A national study in France reported a burnout of 55% during COVID-19 pandemic and he also find out that there was a strong link between the severity of the burnout syndrome, QoL and the impact of COVID-19 pandemic [2, 4]. Health related quality of life (HRQoL) is considered multidimensional and subjective and is assessed by patients using patient reported outcome measures (PROMs). According to WHO, HRQoL is defined as the general perception of individuals of their position in life (i) considering, the culture and value systems and (ii) in relation to expectations, goals, standards, and concerns [4]. HRQoL considers a wide-ranging concept influenced in a complex and interconnected manner by the psychological state, physical health, personal beliefs, social relationships and relationship to prominent features of the environment [5]. A systematic review discussed the impact of COVID-19 on the HRQoL on children and adolescents. Their results showed that lockdown significantly affected QoL, happiness and optimism (p < 0.001), as well as perceived stress. In their findings, the authors reported that only 15.3% (n = 146) of children and adolescents had low QoL before COVID-19 outbreak and during the pandemic, 40.2% of them reported low QoL [6]. A study conducted in the Kingdom of Saudi Arabia [7] assessed the QoL during COVID-19 in the general population and reported that being male (OR = 1.96; 95% CI = [1.31–2.94]), aged between 26 to 35 years (OR = 5.1; 95% CI = [1.33–19.37]), non-Saudi participants (OR = 1.69; 95% CI = [1.06–2.57]), individuals with chronic diseases (OR = 2.15; 95% CI = [1.33–3.48]), loss of job (OR = 2.18; 95% CI = [1.04–4.57]) and participants with depression (OR = 5.70; 95% CI = [3.59–9.05]), anxiety (OR = 5.47; 95% CI = [3.38–8.84]) and stress (OR = 6.55; 95% CI = [4.01–10.70]) were at a high risk of having lower levels of QoL during COVID-19 pandemic and lockdown period [7]. Swedish authors assessed the changes of QoL of the Swedish population using data of February and April 2020 and reported that on visual analogue scale (VAS), the mean QoL reduced from 77.1(SD:17.7) in February to 68.7(SD:68.7) in April 2020, a reduction of 8.4% pre and post pandemic measurements (P<0.000) [8]. In 2021, authors compared the QoL of Brazilian dietitians before (3.83 ± 0.59) and during COVID-19 pandemic (3.36 ± 0.66) and find that the results were statistically different [9]. To the best of our knowledge, this is one of the first systematic reviews to assess the impact of COVID-19 on HRQoL in the general population. The aim and objective of this systematic review is to assess the impact of COVID-19 and associated factors to Health Related Quality of Life in the general population.

Methods

Design and protocol

This systematic review was conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)(Fig 1) [10]. A protocol was registered in the international Prospective Register of Systematic Reviews database (PROSPERO) with the registration number CRD42021269897.

Fig 1. Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) flow diagram.

Fig 1

Eligibility

Articles were included if they were (i) primary and empirical, quantitative, cross-sectional, cohort, case-control, peer reviewed, assessing effects of COVID-19 on the quality of life during COVID-19 in the general population, utilized validated scales for measurement, published in English language from inception to June 30th, 2022. Articles were excluded if (ii) focusing on subgroups of populations such as health care workers, population with previous mental health, population with cancer, HIV or any other chronic disease, utilized secondary data and non-empirical, non-peer review, review articles such as scoping, narrative or Systematic reviews, papers on Medrxiv and SSRN server, comments, letters, conference abstracts, books and book chapters, articles not assessing the quality of life, papers on the population with previous mental health or papers not assessing quality of life in the general population during COVID-19 pandemic. There was no limit on the number of papers to synthetize. All articles satisfied the eligibility criteria were included. Grey literature was used only to support the background section of the research (Table 1).

Table 1. Inclusion and exclusion criteria.

Inclusion Exclusion
Primary, empirical, quantitative, cross-sectional, cohort, case control, peer reviewed, assessing effects of COVID-19 on quality of life before and during COVID in general population, used a validated instrument, is in English language Articles not assessing quality of life, focusing on subgroups of populations such as health workers, population with previous mental health, population with cancer, HIV or any other chronic disease, secondary and non-empirical, non-peer reviews, review articles such as scoping, narrative and Systematic reviews, papers on Medrxiv and SSRN server, comments, letters, conference abstracts, books and book chapters, articles not assessing quality of life, papers with previous mental health problems or papers not assessing quality of life in the general population during the COVID-19 pandemic

Search strategy and selection

A comprehensive electronic search in the PubMed, EBSCO Host Research Databases (Academic Research Complete), MEDLINE (OVID) and Google scholar search engine was conducted from January 5th, 2022 to February 28th, 2022 and updated on June 30th, 2022. The search strategy and data extraction were designed by DAN, DK and JG using Medical Subject Headings (MeSH), field tags and relevant keywords related to quality of life, COVID-19 and general population. Boolean operators, thesaurus, truncation, nesting and quotation marks were used to strengthen the search. The full search strategy was provided in supplementary documents. Additional search of the references from retrieved systematic reviews through snow balling was performed. All retrieved papers were downloaded and saved to Mendeley for intext citations and referencing. The following was used as search string for PubMed; “("Quality of Life"[Mesh] OR “quality of life” [tw] OR “Health-related Quality of Life” [tw] OR HRQoL[tw]) AND ("COVID-19"[Mesh] OR COVID-19[tw] OR “SARS-CoV-2” [tw] OR Sars-cov-2[tw] OR Coronavirus[tw] OR SARS OR “Coronavirus disease 2019” [tw] OR “severe acute respiratory syndrome coronavirus 2” [tw] OR “2019-nCoV Infection” [tw] OR 2019-nCoV[tw] OR “COVID-19 Virus Disease” [tw]) AND (Population[Mesh] OR “general population”[tw] OR “general public”[tw] OR public[tw] OR communit*[tw]).

Data extraction technique

A standardized data collection tool to extract relevant information from papers was designed. The following data was collected; authors, country of publication, study design, sample size, demographic characteristics, HRQoL before COVID-19, HRQoL during COVID-19, QoL measurement tool, statistical tests and risk factors as well as their odds ratios (OR). Data was extracted by two authors (DAN & BW) and verified by the second author (JNM). Discrepancies were resolved by the 3rd author (JG).

Quality appraisal

Two authors (DAN and JG) independently assessed the quality of the included papers using a modified Newcastle-Ottawa Scale (NOS) modified for cross-sectional studies. The quality criteria used in cross-sectional studies were: sample representation, sample size, response rate and validated measurement tools with appropriate cut-off points and the control of confounding variables or use of multiple regression. The quality score ranged between 0 and 5 and any study scoring > or = 3 was considered as high and any study scoring < 3 was considered to be at low quality.

Main outcome

Health related quality of life (HRQoL).

Measures of effect

Health related quality of life measurements such as means of EQ5D and WHOQoL-BREF and their standard deviations were calculated.

Heterogeneity and risk of bias assessment of included studies

The risk of bias, heterogeneity and mean effect size were assessed for EQ5D and WHOQoL_BREF. A random-effect model was fitted to the data. The amount of heterogeneity (i.e., τ2), was estimated using the restricted maximum-likelihood estimator [11]. In addition to the estimate of τ2, the Q-test for heterogeneity [12] and the I2 statistic [13] are reported. In case any amount of heterogeneity is detected (i.e., τ^2>0, regardless of the results of the Q-test), a prediction interval for the true outcomes is also provided [14]. Studentized residuals and Cook’s distances are used to examine whether studies may be outliers and/or influential in the context of the model [15]. Studies with a studentized residual larger than the 100×(1−0.05/(2×k))th percentile of a standard normal distribution are considered potential outliers (i.e., using a Bonferroni correction with two-sided α = 0.05 for k studies included in the meta-analysis). Studies with a Cook’s distance larger than the median plus six times the interquartile range of the Cook’s distances are considered to be influential. The rank correlation test [16] and the regression test [17], using the standard error of the observed outcomes as predictor, are used to check for funnel plot asymmetry. The analysis was carried out using R (version 4.2.1) (R Core Team, 2020) and the metafor package (version 3.8.1) [18].

Qualitative synthesis and quantitative analysis

Data was summarized following the “Institute of Medicine committee on the standards for systematic reviews of comparative effectiveness research: Finding out what works in health care; standards for systematic reviews: recommended standards for qualitative synthesis” [19] and the key characteristics of included studies if similar were grouped, synthetized qualitatively and discussed in order to draw conclusions. The mean effect size was performed and pooled for both EQ5D and WHOQoL_BREF using Random effect model. In meta-analysis, they are two classes of models; fixed and random effect models. For fixed-effect model, all studies are assumed that population effect sizes are the same and are appropriate for drawing inferences on the studies included in the meta-analysis whereas random-effect model attempt to generalize the findings beyond included studies and assume that the selected studies are random samples from a larger population. According to Dettori et al. (2022), the observed effect size is a combination of the study-specific effect and the sampling error [20]. The model is: Yi = B random+Ui+ei, where B random is the average of the true effect sizes, Ui addition of random effect, ei = error. Homogeneity of effect sizes, that is τ2 = 0 can be tested by chi-square statistic which is Q statistic. The τ2 can be used to estimate the degree of heterogeneity. τ2 also depends on the type of effect size used and the common one is I2. I2 is interpreted as the proportion of between-study heterogeneity to the total variation (between–study heterogeneity plus sampling error). When I2 is negative, it is truncated to zero. I2 of 25, 50 and 75% is considered low, moderate and high heterogeneity respectively as a rule of thumb [21]. When conducting a random effect model, it is required to estimate the amount of heterogeneity. The most widely used heterogeneity estimator in medical science is DerSimonian and Laid. Other estimators such as maximum likelihood and restricted maximum likelihood may also be used.

Results

A total number of 1,700,074 articles were identified from electronic databases on PubMed (1,334,241), Medline (OVID) (365,401), EBSCO (Host Research Databases (Academic Research Complete)) (425) and manual search with Google scholar search engine (5). 121,211 duplicates and 1,578,317 papers not related to quality of life were removed and 546 papers were retained. 461 full text papers and abstracts were removed to retain 85 full articles for screening. Finally, 25 full text articles were included for quality synthesis. 8 full articles were excluded because there were no papers with similar instruments to compare and 17 studies were included for quantitative analysis (PRISMA) (Fig 1).

Characteristics of included studies

The total sample size of included studies was N = 22,967 participants and ranges from 225 to 3,002 participants per study. The majority (64.85%) were female (n = 14,894). 3 studies were done in China [2224], 2 Morocco [25, 26], 2 Vietnam [27, 28], 2 Italy [29, 30], 1 Saudi Arabia [7], 1 Malaysia [31, 32], 1 Jordan [33], 1 Philippines [34], 1 Hong Kong [35], 1 Portugal [36], 1 Israel [37], 1 Spain [38], 1 Brazil [39], 1 Scotland [40], 1 USA [41], 1 Egypt [42], 1 study done in two countries Belgium and Netherlands [43] and one in Africa, North America, Asia, Australia, Europe, South America [44]. Nine articles used the WHOQoL-BREF tool to measure the quality of life in their respective countries [7, 3033, 35, 37, 39, 41], six papers utilized the EQ-5D [22, 25, 27, 28, 36, 43], three used SF12/SF-8/ SF36 [24, 26, 38], one utilized EQLS [40], one used GH12 [29], one utilized the COVID-19 QoL questionnaire [44], on used the COVID-19 (COV19- Impact on the quality of life (COV19-QoL) scale) [42] and one utilized MLT [34]. The majority of the studies (n = 23) were of cross-sectional design and only one [40] was of a mixed method. Nine studies utilized the WHOQoL-BREF [7, 3033, 35, 37, 39, 41], nine utilized the EQ-5D [22, 25, 27, 28, 36, 40, 43] among them two studies compared and reported QoL scores before and during COVID-19 [25, 36], three articles utilized the SF12/SF-8/SF36 [24, 26, 38] one article utilized EQLS [40], one paper used GH12 [29]. Another one assessed the HRQoL using COVID-19 QoL questionnaire [44] and one article used MLT [34] to assess HRQoL in general population (Table 2).

Table 2. Mean scores of QoL of included studies.

Study Measurement method QoL before COVID-19 Mean QoL during COVID-19 Most affected domain Least affected domain
1 Algahtani et al. 2021 [7] WHOQOL-BREF NR 39% (SD = NA) Social-relationship Environment
2 Abdullah et al. 2021 [31] WHOQOL-BREF NR 69.44% (SD = 12.78) Social relationship Environment
3. Al-Shannaq et al 2021 [33] WHOQOL-BREF NR 73.21% (SD ¼ 16.17) Social relationship Environment
4 Aruta et al. 2022 [34] MLT NR NA NA NA
5 Azizi et al 2020 [25] EQ-5D-5L 0.91 (SD: NR) During confinement (0.86; P<0.0001
Before confinement (utility = 0.91)
Mobility Anxiety/depression
6 Ballegooijen et al 2021 [43] EQ-5D NR 0.79 (0.77–0.81) Belgium
0.84 (0.82–0.86) Netherlands
NA NA
7 Bonichini & Tremolada, 2021 [29] GH12 NR 17.86 (SD 5.85) NA NA
8 Chen et al. 2021 [22] EQ5D NR 0.990 (SD:N/A) NA NA
9 Choi et al 2021 [35] WHOQoL NR 61.685% (SD = 14.6275) Physical health Environmental health
10 Epifanio et al. 2021 [30] WHOQoL NR 54.48% (SD = 7.77) Physical domain Environment
11 Ferreira et al. 2021 [36] EQ-5D-5L 0.887 (SD = 0.005) 0.861 (SD = 0.027) (During COVID_19)
0.887 (SD = 0.005) (pre-COVID_19)
Anxiety/depression Self-care
12 Khodami et al. 2022 [44] COVID-19 QoL questionnaire NR 21(SD = 21.18) (5(SD: 4.789)) NA NA
13 Lipskaya-Velikovsky (2021) [37] WHOQoL NR 73.5% (IQR:59.5–87.5)
SD: NA
Physical Environment
14 Iglesias-López et al 2021 [38] SF-36 (SF-36v2) NR NA Physical functioning Mental health
15. Ping et al. 2020 [23] EQ-5D NR 0.949 (SD: 0.102)
85.52(SD: 19.37) VAS
Pain/disorder Anxiety/depression
16 Qi et al. 2020 [24] SF8 NR 75.3 (SD = 16.6) physical mental
17 Tran et al. 2020 [27] EQ-5D-5L and EQ-VAS NR 0.95 (± 0.07) and 88.2 (SD: ± 11.0) Anxiety/depression Self-care
18 Vitorino et al. 2021 [39] WHOQoL NR 14.325 (SD = 2.8625) Physical anxiety
19 Quynh Vu et al. 2020 [28] EQ-5D-5L NR 0.95 (general pop) NA NA
20 Yee et al. 2021 [32] WHOQOL-BREF NR 13.2 (SD = 2.8325) Social relationship Environment
21 Campbell & Davison,2022 [40] EQLS NR NA NA NA
22 Hansel et al 2022 [41] WHOQOL-BREF NR 25.1 (SD = 4.9) NA NA
23 Mohsen et al. 2022 [42] COV19- Questionnaire_Quality of Life NR 2.3 (SD = ±0.6) Quality of life in general and perception of danger Perception of mental health perception
24 Samlani Z1 et al. 2020 [26] SF12 NR 70.60 (SD: ±13.1) Mental health Mental health with chronic disease
25. Teotônio et al 2020 [50] WHOQoL-BREEF NR 62.59 (SD = 11.54) Economic Physical

EQLS: European Quality of Life Survey, EQ-5D/EQ-5D-5L: EuroQoL-Five dimensions, WHO_OoL-BREF: World Health Organization Quality of Life BREF; SF12: Short form; COV-19 QoL questionnaire; GH12: The General Health Questionnaire; MLT: My Life Today Questionnaire

Measurement tools

The most used instruments in this study (WHOoQoL and EQ5D) are explained below and a brief description of their normal values for unaffected populations are given at the beginning of each reported instrument. Eight (n = 8) scales have been used to assess health related quality of life on the general population worldwide during COVID-19. EQ-5D: Euro_QoL-Five dimensions; is a preference and generic quality of life instrument to valuate and describe health related quality of life; the higher the index, the better the health. It describes health in terms of five dimensions; mobility, self-care, usual activities, pain/discomfort and anxiety/depression [45]. A utility score can be generated from the five dimensions based on a published algorithm with a value of 0 for death and 1 for perfect health. WHO_OoL-BREF: the WHO_BREF is a 26-item instrument with four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items) [46]. It is scored from 1 to 5 on a response scale but transformed linearly to a 0 to 100 scale. 0 point represent the worse possible health state while 100 points represent the best possible health state. SF12: Short form are generic health survey short-forms (don’t use preference based approach) to assess quality of life which are used in research and clinical practice, health policy and general surveys [47]. EQLS: European Quality of Life Survey is a 2012 scale which considers the following dimensions; employment and work-life balance, family and social life, health and public services, home and local environment, quality of society, social exclusion and community involvement, standard of living and deprivation, subjective well-being which is designed for the general population[48]. GHQ: General Health Questionnaire is a measure of current mental health and since its development by Goldberg in the 1970s it has been extensively used in different settings and different cultures [49]. COV19-QoL is a 6-item scale covering main areas of quality of life in relation to mental health. The first item covers patients’ feelings about the impact of the current pandemic on their quality of life in general population. The second and third include the participants’ perceptions of possible mental and physical health deterioration. COV19-QoL scale is a recently developed specific reliable and valid tool assessing perceptions of deterioration in QoL as a result of the COVID-19 pandemic [42]. MLT: My Life Today the 9-tem (4) scale was used to measure the participants’ perceptions of various life domains, including the assessment of life in general population [34].

Quality of life before and during COVID-19

Among 25 articles reporting changes in QoL, 23 reported the mean QoL only during COVID-19 and did not report the QoL before COVID-19. Nine papers [22, 25, 27, 28, 36, 40, 43] utilized EQ5D among them only two reported both QoL before COVID-19 as compared to that of during COVID-19 [25, 36] using EQ5D instrument. Azizi et al. (2020) in Morocco reported an EQ5D mean score before COVID-19 of 0.91(SD: NR) and 0.86 (SD: NR) during the pandemic. This makes a drop of 0.05 on QoL. Ferreira et al. (2021) in Portugal also reported an EQ5D mean score before COVID-19 of 0.887 (SD: NR) and 0.861 (SD: NR) during COVID-19 making a drop of 0.026 of QoL. Using EQ5D, the minimum score reported during COVID-19 was 0.79 (SD: 0.17–1.41) and a maximum of 0.95 (SD:.14–1.76) with a mean score 0.89 (SD: 0.66–1.13). Among papers reporting QoL using WHOQoL, no study reported both scores (before and after) and the WHOQoL minimum score reported during COVID-19 was 13.20 (SD: 9.85, 16.55) with a maximum of 73.50 (SD:66.14, 80.86). The mean reported was 53.38 (SD:38.50, 68.27). The lower the score, the lower the QoL. The rest of quality of life instruments were used at least once making it not practical to report their means for a comparison.

Forest plot WHO_BREF

A total of k = 9 studies were included in the analysis. The observed outcomes ranged from 13.2000 to 73.5000, with the majority of estimates being positive (100%). The estimated mean outcome based on the random-effects model was μ^=53.3841 (95% CI: 38.4992 to 68.2691). Therefore, the average outcome differed significantly from zero (z = 7.0293, p<0.0001). A forest plot showing the observed outcomes and the estimate based on the random-effects model is shown (Fig 2)

Fig 2. Mean score using WHOQoL-BREF forest plot.

Fig 2

Study1 [7], study2 [31], Study3 [33], Study4 [35], Study5 [7], Study6 [37], Study 7 [32], Study8 [41], study 9 [50]. The mean health related quality of life using WHOQoL_BREF is estimated at 53.38.

Forest plot EQ5D

A total of k = 8 studies were included in the analysis. The observed outcomes ranged from 0.7900 to 0.9900, with the majority of estimates being positive (100%). The estimated average outcome based on the random-effects model was μ^=0.8930 (95% CI: 0.6566 to 1.1295). Therefore, the average outcome differed significantly from zero (z = 7.4024, p<0.0001). A forest plot showing the observed outcomes and the estimate based on the random-effect model is shown (Fig 3)

Fig 3. Mean score using EQ5D forest plot.

Fig 3

Study 1 [25], Study2 [43], Study3 [43], Study4 [22], Study5 [36], Study6 [23], Study7 [27], Study8 [28].

Heterogeneity and risk of bias of WHO-BREF studies

According to the Q-test, the true outcomes appear to be heterogeneous (Q(8) = 656.8283, p<0.0001, τ^2=509.6543, I2 = 99.2019%). A 95% prediction interval for the true outcome is given by 6.7003 to 100.0680. Hence, even though there may be some heterogeneity, the true outcomes of the studies are generally in the same direction as the estimated average outcome.

A funnel plot of the estimates is shown in (Fig 4). The regression test indicated funnel plot asymmetry (p = 0.0019) but not the rank correlation test (p = 0.1194) (Fig 4).

Fig 4. WHOQoL-BREF funnel plot.

Fig 4

Study1 [7], study2 [31], Study3 [33], Study4 [35], Study5 [7], Study6 [37], Study 7 [32], Study8 [41], study 9 [50].

Heterogeneity and risk of bias of EQ5D studies

According to the Q-test, there was no significant amount of heterogeneity in the true outcomes (Q(7) = 0.3149, p = 0.9999, τ^2=0.0000, I2 = 0.0000%). A funnel plot of the estimates is shown in (Fig 5). Neither the rank correlation nor the regression test indicated any funnel plot asymmetry (p = 0.5664 and p = 0.8657, respectively) (Fig 5).

Fig 5. EQ5D funnel plot.

Fig 5

Study 1 [25], Study2 [43], Study3 [43], Study4 [22], Study5 [36], Study6 [23], Study7 [27], Study8 [28].

Quality assessment

We used the Modified Newcastle-Ottawa quality assessment scale tool to assess the quality of included papers and only 3 papers scored five out five (5/5) [29, 36, 39]. Ten papers scored four out of five (4/5) [7, 22, 23, 30, 31, 33, 35, 38, 42, 44]. Eight studies scored three out five (3/5) [24, 27, 28, 32, 34, 38, 43]. Only three papers [25, 26, 40] scored 2 out five making it the lowest score and therefore low quality. We included the three low quality articles in the qualitative synthesis however only one low quality paper [25] was included in the quantitative analysis (meta-analysis) because it was lying within two standard deviations of the mean therefore it was not affecting the results (Table 3).

Table 3. Modified Newcastle-Ottawa quality assessment scale.

Author & year of publication Sample representativeness Sample size (>500) Response rate Study used validate measurement tools with appropriate cut-offs Control of confounding variables or used multiple regression Score
1.Algahtani et al. 2021 + + - + + 4
2. Abdullah et al. 2021 + - + + + 4
3. Al-Shannaq et al 2021 + - + + + 4
4. Aruta et al. 2022 + - _ + + 3
5. Azizi et al 2020 + - - + - 2
6. Ballegooijen et al 2021 + + - + - 3
7. Bonichini & Tremolada, 2021 + + + + + 5
8. Chen et al. 2021 + + - + + 4
9. Choi et al 2021 + - + + + 4
10. Epifanio et al. 2021 + + _ + + 4
11. Ferreira et al. 2021 + + + + + 5
12. Khodami et al. 2022 + + - + + 4
13. Lipskaya-Velikovsky (2021) + - _ + + 3
14. Iglesias-López et al 2021 + + + + 4
15. Ping et al. 2020 + + _ + + 4
16. Qi et al. 2020 + + - + _ 3
17 Tran et al. 2020 + - _ + + 3
18. Vitorino et al. 2021 + + + + + 5
19. Vu et al. 2020 + - + + - 3
20. Yee et al. 2021 + - - + + 3
21. Campbell and Davison,2022 + - - + _ 2
22. Tonya Cross Hansel et al 2022 + _ + + 3
23. Shorouk Mohsen et al. 2022 + - _ + + 4
24. Samlani Z1 et al. 2020 + - _ + - 2
25. Teotônio et al 2020 + + + + - 4

Key: 1. Sample representativeness (= 65% of the sample), 2.sample size> 600 participants, 3. response rate>80%, 4. study used validate measurement tools with appropriate cut-offs and 5 control of confounding variables or used multiple regression

Quality of life and factors associated to the low HRQoL

EQ-5D

Eight studies [22, 25, 27, 28, 36, 40, 43] have used the EQ-5D to assess the quality of life for the general population during COVID-19 pandemic. The mean score using EQ-5D estimated at 0.89 [95% CI 0.66–1.13]. By using EQ-5D, authors [25] reported the results (before and during confinement) that the quality of life was affected in the five health dimensions; mobility 87%(87%), self-care 97%(93%), usual activities 82%(89%), pain/discomfort 70%(78%) and anxiety/depression 44%(66%). His comparison on the two samples showed that during confinement, peoples had lower scores of HRQoL at 0.86 (p<0.001) as compared to before confinement whose score was 0.91 [25]. Female gender was affected with lower scores of HRQoL than their counterpart male on both utility (0.85; P = <0.0001 and VAS (78.49; P = 0.004) and (utility = 0.89 and VAS = 83.78) respectively. Marital status was significantly associated to EQ-5D utility (P = 0.002) and VAS (P = 0.005) scores, widowed had the worst HRQoL (utility = 0.43 and VAS = 48.75) compared to single (utility = 0.87 and VAS = 80.09), married (utility = 0.86 and VAS = 81.43), and separated (utility = 0.89 and VAS = 80.15) participants. Participants with university education had the higher EQ-5D utility score (0.88; p<0.001) and age did not have a significant impact. A study done in Belgium and Netherlands also evaluated the quality of life using EQ5D as well, a minority in both countries felt stressed with 27% and 14% respectively [43]. The majority reported concerns about their personal current and future financial situation (59 and 48% respectively) and the national economies (88 and 86%). Specifically, in Belgium, the EQ-5D before COVID-19 measured 0.82 (95% CI; 0.80–0.84) and during COVID-19 measures 0.79 (95% CI; 0.77–0.81). In Netherlands, before COVID-19, 0.85 (95% CI; 0.83–87) and during COVID-19 outbreak, it was 0.84 (95% CI; 0.82–0.86). Chen et al. (2021), using EQ5D concluded that the mean EQ-5D score and VAS were 0.99 and 93.5. Their multiple linear regression showed that the quality of life measure was related to physical activities (β = 0.006) and keeping home ventilation (β = 0.063) in Daqing, and were related to wearing a mask when going out (β = 0.014), keeping home ventilation (β = 0.061), other marital status (β = − 0.011), worry about the epidemic (β = − 0.005) and having a centralized or home quarantine (β = − 0.005) in Taizhou [22]. Using EQ5D, authors concluded that those quarantined at home experienced higher levels of anxiety and a lower HRQoL compared with the pre-COVID-19 pandemic population. Females and elderly individuals experienced the highest levels of anxiety and poorest HRQoL (OR not reported) [36]. Other authors [23] using the same instrument EQ5D reported that the risk of pain/discomfort and anxiety/depression in general population in China raised significantly with aging, with chronic disease, lower income, epidemic effects, worried about get COVID-19 during the COVID-19 pandemic (OR not reported) [23]. Tran et al. (2020) With the same instrument EQ5D (n = 341) reported that 66.9% of household income loss was due to the impact of COVID-19. The mean score of EQ-5D and EQ-VAS was 0.95 (SD ± 0.07) and 88.2 (SD ± 11.0) respectively. The domain of Anxiety/Depression had the highest proportion of reporting any problems among 5 dimensions of EQ-5D (38.7%). Being female, having chronic conditions and living in the family with 3–5 members were associated with lower HRQOL score (OR not reported) [27]. Vu et al. (2020) using EQ5D reported the highest mean EQ-VAS at 90.5 (SD: 7.98) among people in government quarantine facilities, followed by 88.54 (SD: 12.24) among general population and 86.54 (SD 13.69) among people in self-isolation group [28]. The EQ-5D value was reported as the highest among general population at 0.95 (SD: 0.07), followed by 0.94 (SD: 0.12) among people in government quarantine facilities, and 0.93 (SD: 0.13) among people who put themselves in self-isolation. Overall, most people, at any level, reported having problems with anxiety and/or depression in all groups.

WHOQoL-BREF

The WHOQoL average scores was estimated at 50.55% 95% CI [32.19–68.90]. Authors by using WHOQoL-BREF reported a quality of life affected with a score of 39% (CI not reported) and according to authors, males were more affected with OR = 1.96 (95% CI = 1.31–2.94); participants aged 26 to 35 years OR = 5.1; (95% CI = 1.33–19.37); non-Saudi participants OR = 1.69 (95% CI = 1.06–2.57); individuals with chronic diseases OR = 2.15 (95% CI = 1.33–3.48); those who lost their job OR = 2.18 (95% CI = 1.04–4.57) and those with depression OR = 5.70 (95% CI = 3.59–9.05), anxiety OR = 5.47; (95% CI = 3.38–8.84), and stress OR = 6.55 (95% CI = 4.01–10.70) [7].

In 2021, a study [31] concluded that higher psychological QoL reduced the odds of depressive symptoms OR = 0.83 (95% CI = 0.69–0.99, p = 0.032) and depressive with comorbid anxiety symptoms OR = 0.82, (95% CI = 0.68–0.98, p = 0.041), whereas higher physical health QoL OR = 0.85, (95% CI = 0.75–0.97, p = 0.021) and social relationship QoL OR = 0.70 (95% CI = 0.55–0.90, p = 0.009) reduced the odds of anxiety symptoms [31]. In 2020, a study [33] had reported a mean for total QoL score of 73.21 (SD ¼ 16.17). The mean general QoL and health scores were 3.15 (SD ¼ 0.94) and 3.40 (SD ¼ 0.95). As for the four QoL subscales, the mean scores in each domain were as follows: 18.04 (SD ¼ 4.39) for physical health, 17.65 (SD ¼ 3.77) for psychological health, 8.69 (SD ¼ 2.67) for social relationships, and 22.29 (SD ¼ 5.84) for environment(29). Choi et al (2021), using the same QoL scale reported that 69.6% of participants were worried about contracting COVID-19, and 41.4% frequently suspected themselves of being infected whereas 29.0% were concerned by the lack of disinfectants. All of these findings were associated with poorer HRQoL in the physical and psychological health, social relationships, and environment domains (OR not reported). 47.4% of participants were concerned that they may lose their job because of the pandemic and 39.4% were bothered by the insufficient supply of surgical masks [35]. The results of a study [30] showed statistically significant difference in QoL depending on a number of variables, including sex, area of residence in Italy, and being diagnosed with a medical/psychiatric condition (OR: NR). The overall average score at the WHOQoL-BREF was 54.48 (SD = 7.77). The item with the lowest scores was 14 (about the use of spare time), given that 932 (41.4%) participants reported to have little or no time for leisure at the time of data collection. Regarding the other three domains of the WHOQoL, items with lowest scores were: item 15 for the physical domain, as 1019 (45.3%) participants reported little or no possibility to do physical activity; item 5 for the psychological domain, with 712 (31.6%) respondents reporting that they were not enjoying their lives at the time of data collection, and item 21 for social relationships, as 843 (37.4%) respondents reported that they were little or not at all satisfied with their sexual life [30]. A research in 2021 [37] reported that COVID-19 has had a wide impact on the general population, with the potential for negative secondary impacts. Women, young adults, and the unemployed are at high risk for secondary effects (ORs:NR). Another study [39] scores on the social relationships QoL domain were lower among participants who had a family member or friend with COVID-19 and among those who engaged in negative forms of spiritual religious coping (SRC). The quarantine during the COVID-19 pandemic has limited personal contact with family and friends, adversely affected sexual activity, and has restricted other activities that are assessed in the social relationships QoL domain. Positive forms of spiritual religious coping (SRC) were associated with better scores on this domain, as reported in other studies [37]. In 2020, a study [32] highlighted that approximately one in three individual experienced mild-to-severe depressions during the nationwide movement control order (MCO). The results of a study [41] reported that most would expect quality of life to be challenged during a global pandemic; however, when behavioral health assessed as a component of overall quality of life, longer term outcomes became concerning [41].

SF12/SF-8/ SF36

Samlani et al. (2020) by using SF 12/8 (Chinese) scale, all participants obtained a total average score of 70.60 (±13.1) with a mental health score (MCS) of 34.49 (±6.44) and a physical health score (PCS) of 36.10 (± 5.82). The physical (PCS) and mental (MCS) scores of participants with chronic diseases were 32.51 (±7.14) and 29.28 (±1.23), respectively. Overall, the participants’ PCS and MCS scores suffered from chronic diseases and the elderly participants were lower than those of young participants without comorbidities(23). López et al (2021) reported the following results using SF-36; the presence of pain in subjects undergoing confinement was persistent, with varying intensity and frequency based on age, gender, physical activity, and work status (OR:NR). In any of these conditions, the quality of life of the subjects in confinement has been severely affected [38]. Qi et al. 2020 using–SF8 (Chinese), participants’ average physical component summary score (PCS) and mental component summary score (MCS) for HRQoL were 75.3 (SD = 16.6) and 66.6 (SD = 19.3), respectively. More than half of participants (53.0%) reported moderate levels of stress. Significant correlations between physical activity participation, QoL, and levels of perceived stress were observed (p < 0.05). Prolonged sitting time was also found to have a negative effect on QoL (p < 0.05) [24].

EQLS

Campbell & Davison (2022) by using EQLS found that there are strong relationships between QoL and income, disability and living arrangement as well as social isolation and Disability and living arrangement [40]. Correlation and multiple regression analyses showed a strong relationship between social isolation, gratitude, uncertainty and QoL with social isolation being a significant predictor (OR not reported).

GH12

Bonichini & Tremolada (2021) reported that the mean GH12 score in participants amounted to 17.86 (SD = 5.85), reflecting a contingent moderate stressful impact on QoL. GH12 identified 39% of respondents as having subclinical QoL scores (score ≥ 15). 24.5% of such respondents as having very problematic scores (score ≥ 19), and 36.5% of such respondents as having normal scores (score < 15). Analysis of variance (ANOVA) showed there was a significant difference (F(2, 1.836) = 5.50, p = 0.004, η 2 = 0.01) in mean GH12 scores [29].

COVID-19 QoL questionnaire

The results of Khodami et al. (2022) showed that Quality of life is significantly decreased over time, perceived stress level raised significantly and an increased level of difficulty in emotion regulation has happened. Younger peoples and individuals who had a worsening quality of life response tended to show more stress and emotion regulation problems [44]. Mohsen et al. (2022) using COVID-19 on Quality of life scale reported that the total COV19-QoL scale score was 2.3±0.6. Two items show the highest mean with 2.6±0.7 (quality of life in general and perception of danger on their personal safety) indicating the poorest quality of life regarding these 2 items. However, the lowest mean score was related to the perception of mental health deterioration (1.9±0.8). Significant variables in the bivariate analysis revealed that sex (regression coefficient = 0.1 (95% CI(0.02 to 0.2), p value = 0.02), monthly income (regression coefficient (95% CI) = 0.1 (0.004 to 0.2), p value = 0.04), knowing someone infected with COVID19 (regression coefficient (95% CI) = 0.15 (0.08 to 0.3), p value = 0.001), and data collection time (regression coefficient (95% CI) = 0.1 (0.006 to 0.2), p value = 0.04) were the independent predictors for overall QoL scale score [42].

MLT

Aruta et al. (2022) by using MLT questionnaire, the results of the path analysis indicated a good data‐model fit: (χ 2 = 4.97, df = 2, p = 0.08; CFI = 0.99, TLI = 0.96, SRMR = 0.02, RMSEA [90% CI] = 0.06 [0.000 − 0.13]). The direct effects of safety at home (B = −0.27, β = −0.21, SE = 0.05, p ≤ 0.001), TPIs (B = −0.19, β = −0.27, SE = 0.05, p ≤ 0.001), and financial difficulties (B = 0.15, β = 0.18, SE = 0.05, p ≤ 0.001) on psychological distress were found to be significant. Direct effects of safety at home (B = 0.19, β = 0.22, SE = 0.05, p ≤ 0.001), TPIs (B = 0.18, β = 0.27, SE = 0.04, p ≤ 0.001), financial difficulties (B = −0.15, β = −0.21, SE = 0.05, p ≤ 0.001), and psychological distress (B = −0.29, β = −0.34, SE = 0.04, p ≤ 0.001) on quality of life were found to be significant. Results indicated that psychological distress partially mediated the positive influence of safety at home (B = 0.06, β = 0.07, SE = 0.02, p ≤ 0.001) and TPIs (B = 0.06, β = 0.09, SE = 0.02, p ≤ 0.001) on quality of life [34]. These findings indicate that psychological distress is a mechanism that can partly explain why socio‐ ecological factors (i.e., safety at home, financial difficulties, and trust in institutions) impact the quality of life of Filipino adults during COVID‐19.

Discussion

Findings of included studies demonstrated how COVID-19 pandemic reduced the QoL of the general population. Different factors influenced directly or indirectly the change of QoL. Researchers utilized different quality of life measurement scales among them EQ-5D leading the pool of measurement scales followed by WHOQoL-BREF then SF12/SF-8/ SF36 as 3rd scale and the rest. For studies that used EQ-5D to assess the impact of quality of life, all five dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) were affected significantly with a mean EQ-5D score of 0.89 with 95% CI [-1.865–2.048] with the lowest score of 0.79 at 95% CI (NR) and upper score of 0.99 at 95% CI (NR) [25]. The mean WHOQoL-BREF score was estimated at 50.55 with a 95% CI [32.19, 68.90]. Other instruments such as SF12 scored 70.60 with 95% CI [57.5, 83.7], SF8 scored QoL at 75.3 with 95% CI [58.7, 91.9] and SF36 (score NR). In low and middle income countries (LMICs) such as Morocco [25] using EQ-5D reported low QoL during confinement as compared to before in the 5 health dimensions respectively; mobility 87%(87%), self-care 97%(93%), usual activities 82%(89%), pain/discomfort 70%(78%) and anxiety/depression 44%(66%) with average QoL at 0.91 (p<0.001) before and 0.86 (0.001) after confinement. Whereas in high income countries (HICs), Belgium for example using EQ-5D before COVID-19 QoL measured 0.82 (95% CI; 0.80–0.84) and during COVID-19 measures 0.79 (95% CI; 0.77–0.81), the same with Netherlands, before COVID-19 EQ-5D measured 0.85 (95% CI; 0.83–0.87) before and during COVID-19 0.84 (95% CI; 0.82–0.86). A research in China, using EQ5D concluded that the mean EQ-5D score and VAS were 0.99 before COVID-19 and 93.5 during COVID-19. When compared HICs and LMICs, both countries were affected significantly by COVID-19 and this was exacerbated by confinement [51]. These results are in line with those of a Chinese study with an average score EQ-5D of 0.949 and VAS score 85.52 [22]. Nine published papers assessed QoL using WHOQoL [7, 3033, 35, 37, 39, 41] and their mean score was 50.55% with 95% CI [32.19–68.90]. The lower the score, the lower the quality of life. On the other hand, using EQ-5D, the mean score was estimated at 0.89 with 95% CI [0.66–1.13] with the same trend, the lower the score, the lower the quality of life. Our study findings are different from those published in Vietnam that reported EQ5D score 0.95 (SD = NR.) during the national social distancing, against our results (mean EQ5D = 0.89) [27]. This might be because it is an empirical study while our study summarizes results from a variety of studies making our mean score low. Our main findings rely most on EQ5D and WHOQoL instrument reports. Although, we assessed QoL of the general population during COVID-19 (Mean EQ5D = 0.89), some authors assessed the impact of some chronic diseases on QoL of the general population such as type 2 diabetes [52] (EQ5D = 0.8 SD = 0.20), human immunodeficiency virus (HIV) [53] (EQ5D = 0.8 SD = 0.2), skin disease [54] (EQ5D = 0.73 SD = 0.19), respiratory diseases (EQ5D = 0.66 SD = 0.31), dengue fever (EQ5D = 0.66 SD = 0.24), frail elderly in Vietnam [55] (EQ5D = 0.58 SD = 0.20), elderly after fall injury and facture injuries (EQ5D = 0.46 SD = NR). QoL in general population during COVID-19 was comparable to that of type2 diabetes and HIV. This may be because Type2 diabetes and HIV are chronic conditions, patients are stable on medication if the management and compliance to medications is respected. QoL of skin disease patients, respiratory diseases, dengue fever, frail elderly, elderly after fall and fracture injuries were low as compared to COVID-19 general population. This may be due to the high score of pain involved in these conditions. Different factors that contributed to low quality of life have been identified; age, gender, education level, marital status, financial constraints, confinement, fear of being contaminated and individual with other chronic conditions. The two measurement scales were the most utilized instruments as compared to the other scales and their results show a considerable reduced quality of life. Using WHOQoL-BREF [7] reported a quality of life affected with a score of 39% (CI = NR) and according to authors, males were more affected probably because in developing countries, males are responsible of financial support to the family and because of that, they may fear either confinement that affects job market or else being contaminated and not able to work for their families. Concerning age, participants aged 26-35years were more affected and the reason may be because most peoples of this age bracket are the young couples or single mothers therefore the young fathers were worried about their families and finances if they are quarantined. Females were more affected than their counterparts according to [25] this may be due to the fact that females naturally are the nuclear parts of a family and their emotions towards the family therefore become much worried than males. Widowers had the worst quality of life and this may be due to their worries about their life and that of their children with less psychological support [56, 57] from their spouses. Individuals with chronic diseases (hypertension, Type2 diabetes, asthma, stress, anxiety, depression, etc…) had a high risk of low quality of life and this might be because they are vulnerable to COVID-19 with high fear of contamination therefore pushing them to low quality of life. Other factors such as confinement, financial constraints, fear of being contaminated with COVID-19 and having a contaminated family member increased the likelihood of anxiety, stress and depression therefore leading to the low individual quality of life [58]. The main reason of stress due to confinement is due to financial constraint because a confined person is not allowed to work and generate income to sustain the family during the pandemic. It is surprising that both low and high income countries were affected by COVID-19 reducing their population quality of life. This shows how no country in the world was prepared for any huge health pandemic whether rich or poor. This highlights the low level of preparedness for countries to face similar catastrophic situations. What is lacking? Is it the money or strategies? Developed countries can afford to provide necessary means to fight against pandemics but there is no guaranty to protect the populations from dying before actions are in place. For this purpose, there is a need to strengthen infectious disease predictions and modeling using machine learning or artificial intelligence. There is a need to embrace and exploit artificial intelligence to improve the prediction of future events to prevent populations from diseases and death and maintain their maximum quality of life.

Strengths and weaknesses

First and the foremost, the strength of this review is that, it was conducted according to the international guidelines for systematic reviews after registration of the protocol in international database PROSPERO. Secondly, it was conducted two and half years after the pandemic begun and authors already have published enough papers to allow robust systematic synthesis of results. And the results can be generalized as papers were searched Worldwide with a reasonable sample size (22,967 participants).

There were also some limitations; We searched papers in English only leaving probably out some studies. The fact that we searched only 3 databases and a search engine, some articles might have been missed. The generalizability should be done with caution. Most studies reported the mean QoL during COVID-19 with no baseline to compare, this can weaken our results. All studies were cross-sectional and there were no cohort or case control studies, this can also weaken our conclusions.

Conclusion

This systematic review confirms that the COVID-19 pandemic affected negatively health related quality of life of the general population. Several factors influencing quality of life of general population through COVID-19 have been identified; age, sex, marital status, education, peoples living with chronic diseases, confinement and financial constraints among others, etc…. There was no significant difference between the impact of COVID-19 in general population in high income countries and low and middle income countries. Three quality of life scales were mainly used to assess the quality of life of the general population; WHO-QoL-BREEF, EQ-5D, SF and others. The findings of this review will be useful for policy makers and health managers to facilitate the planning and prevention of quality of life of the general population during future pandemics. We recommend cohort and case control studies on impact of COVID-19 on quality of life to collect more and strong evidence on impact of COVID-19 on different population in the world. We are also recommending studies on prediction and modeling of infectious diseases using machine learning and artificial intelligence to prevent the population from future pandemics to maintain the population quality of life.

Supporting information

S1 Checklist. PRISMA checklist.

(DOC)

S1 Table. Summary of included studies.

(DOCX)

S1 Text. PubMed search string.

(DOCX)

Acknowledgments

The authors acknowledge the moral support from their families, friends and colleagues.

Data Availability

A protocol was registered in the international Prospective Register of Systematic Reviews database (PROSPERO) registration number (CRD42021269897).

Funding Statement

The authors received no specific funding for this work.

References

  • 1.WHO. COVID 19 Public Health Emergency of International Concern (PHEIC) Global Research and Innovation Forum: Towards a Research Roadmap. Glob Res Collab Infect Dis Prep [Internet]. 2020;1–10. Available from: https://www.who.int/publications/m/item/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum [Google Scholar]
  • 2.Nam NH, Tien PTM, Truong LV, El-Ramly TA, Anh PG, Hien NT, et al. Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly. PLoS One. 2021. Jul 15;16(7):e0254012. doi: 10.1371/journal.pone.0254012 ; PMCID: PMC8282022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Phan L. et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J Affect Disord. 2020. Dec 1;277:55–64. doi: 10.1016/j.jad.2020.08.001 Epub 2020 Aug 8. ; PMCID: PMC7413844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Aronson KI, Suzuki A. Health Related Quality of Life in Interstitial Lung Disease: Can We Use the Same Concepts Around the World? Front Med (Lausanne). 2021. Oct 6;8:745908. doi: 10.3389/fmed.2021.745908 ; PMCID: PMC8526733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Taylor S, Paluszek MM, Rachor GS, McKay D, Asmundson GJG. Substance use and abuse, COVID-19-related distress, and disregard for social distancing: A network analysis. Addict Behav. 2021. Mar;114:106754. doi: 10.1016/j.addbeh.2020.106754 Epub 2020 Dec 3. ; PMCID: PMC8164919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Nobari H, Fashi M, Eskandari A, Villafaina S, Murillo-Garcia Á, Pérez-Gómez J et al. Effect of COVID-19 on Health-Related Quality of Life in Adolescents and Children: A Systematic Review. Int J Environ Res Public Health. 2021. Apr 25;18(9):4563. doi: 10.3390/ijerph18094563 ; PMCID: PMC8123423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Algahtani FD, Hassan SU, Alsaif B, Zrieq R. Assessment of the Quality of Life during COVID-19 Pandemic: A Cross-Sectional Survey from the Kingdom of Saudi Arabia. Int J Environ Res Public Health. 2021. Jan 20;18(3):847. doi: 10.3390/ijerph18030847 ; PMCID: PMC7863741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lindqvist Bagge AS, Carlander A, Fahlke C, Olofsson Bagge R. Health-related quality of life (FACT-GP) in Sweden. Health Qual Life Outcomes. 2020. Jun 8;18(1):172. doi: 10.1186/s12955-020-01420-1 ; PMCID: PMC7278202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.da Costa Matos RA, Akutsu RCCA, Zandonadi RP, Botelho RBA. Quality of Life Prior and in the Course of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study with Brazilian Dietitians. Int J Environ Res Public Health. 2021. Mar 8;18(5):2712. doi: 10.3390/ijerph18052712 ; PMCID: PMC7967437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097 Epub 2009 Jul 21. ; PMCID: PMC2707599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Viechtbauer W. Bias and efficiency of meta-analytic variance estimators in the random-effects model. J Educ Behav Stat. 2005;30(3):261–93. 10.3102/10769986030003261 [DOI] [Google Scholar]
  • 12.van Aert RCM, van Assen M, Viechtbauer W. Statistical properties of methods based on the Q-statistic for constructing a confidence interval for the between-study variance in meta-analysis. Res Synth Methods. 2019. Jun;10(2):225–239. doi: 10.1002/jrsm.1336 Epub 2019 Jan 28. ; PMCID: PMC6590162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Khan MS, Li L, Yasmin F, Khan SU, Bajaj NS, Pandey A, et al. Assessment of Heterogeneity in Heart Failure-Related Meta-Analyses. Circ Heart Fail. 2020. Nov;13(11):e007070. doi: 10.1161/CIRCHEARTFAILURE.120.007070 Epub 2020 Nov 2. . [DOI] [PubMed] [Google Scholar]
  • 14.Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011. Feb 10;342:d549. doi: 10.1136/bmj.d549 . [DOI] [PubMed] [Google Scholar]
  • 15.Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010. Apr;1(2):112–25. doi: 10.1002/jrsm.11 Epub 2010 Oct 4. . [DOI] [PubMed] [Google Scholar]
  • 16.Gjerdevik M, Heuch I. Improving the error rates of the Begg and Mazumdar test for publication bias in fixed effects meta-analysis. BMC Med Res Methodol. 2014. Sep 22;14:109. doi: 10.1186/1471-2288-14-109 ; PMCID: PMC4193136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.McShane BB, Böckenholt U, Hansen KT. Adjusting for Publication Bias in Meta-Analysis: An Evaluation of Selection Methods and Some Cautionary Notes. Perspect Psychol Sci. 2016. Sep;11(5):730–749. doi: 10.1177/1745691616662243 . [DOI] [PubMed] [Google Scholar]
  • 18.Viechtbauer W. Conducting meta-analyses in R with the metafor. J Stat Softw. 2010;36(3):1–48. 10.18637/jss.v036.i03 [DOI] [Google Scholar]
  • 19.Institute of Medicine (US) Committee on Standards for Systematic Reviews of Comparative Effectiveness Research. Finding What Works in Health Care: Standards for Systematic Reviews. Eden J, Levit L, Berg A, Morton S, editors. Washington (DC: ): National Academies Press (US); 2011. doi: 10.17226/13059 [DOI] [PubMed] [Google Scholar]
  • 20.Dettori JR, Norvell DC, Chapman JR. Fixed-Effect vs Random-Effects Models for Meta Analysis: 3 Points to Consider. Global Spine J. 2022. Sep;12(7):1624–1626. doi: 10.1177/21925682221110527 Epub 2022 Jun 20. ; PMCID: PMC9393987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.von Hippel PT. The heterogeneity statistic I(2) can be biased in small meta-analyses. BMC Med Res Methodol. 2015. Apr 14;15:35. doi: 10.1186/s12874-015-0024-z ; PMCID: PMC4410499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Chen X, Xu Q, Lin H, Zhu J, Chen Y, Zhao Q, et al. Quality of life during the epidemic of COVID-19 and its associated factors among enterprise workers in East China. BMC Public Health. 2021. Jul 10;21(1):1370. doi: 10.1186/s12889-021-11414-3 ; PMCID: PMC8271302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ping W, Zheng J, Niu X, Guo C, Zhang J, Yang H, et al. Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic. PLoS One [Internet]. 2020;15(6):1–12. 10.1371/journal.pone.0234850 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Qi M, Li P, Moyle W, Weeks B, Jones C. Physical Activity, Health-Related Quality of Life, and Stress among the Chinese Adult Population during the COVID-19 Pandemic. Int J Environ Res Public Health. 2020. Sep 7;17(18):6494. doi: 10.3390/ijerph17186494 ; PMCID: PMC7558071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Azizi A, Achak D, Aboudi K, Saad E, Nejjari C, Nouira Y,et al. Health-related quality of life and behavior-related lifestyle changes due to the COVID-19 home confinement: Dataset from a Moroccan sample. Data Brief. 2020. Oct;32:106239. doi: 10.1016/j.dib.2020.106239 Epub 2020 Aug 27. ; PMCID: PMC7449885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Samlani Z, Lemfadli Y, Ait Errami A, Oubaha S, Krati K. The impact of the COVID-19 pandemic on quality of life and well-being in Morocco. Arch Community Med Public Heal. 2020;11(2):130–4. Available on https://www.peertechzpublications.com/articles/ACMPH-6-191.php [Google Scholar]
  • 27.Tran BX, Nguyen HT, Le HT, Latkin CA, Pham HQ, Vu LG, et al. Impact of COVID-19 on Economic Well-Being and Quality of Life of the Vietnamese During the National Social Distancing. Front Psychol. 2020. Sep 11;11:565153. doi: 10.3389/fpsyg.2020.565153 ; PMCID: PMC7518066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Vu MQ, Tran TTP, Hoang TA, Khuong LQ, Hoang MV. Health-related quality of life of the Vietnamese during the COVID-19 pandemic. PLoS One. 2020. Dec 18;15(12):e0244170. doi: 10.1371/journal.pone.0244170 ; PMCID: PMC7748152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bonichini S, Tremolada M. Quality of Life and Symptoms of PTSD during the COVID-19 Lockdown in Italy. Int J Environ Res Public Health. 2021. Apr 20;18(8):4385. doi: 10.3390/ijerph18084385 ; PMCID: PMC8074764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Epifanio MS, Andrei F, Mancini G, Agostini F, Piombo MA, Spicuzza V, et al. The Impact of COVID-19 Pandemic and Lockdown Measures on Quality of Life among Italian General Population. J Clin Med. 2021. Jan 14;10(2):289. doi: 10.3390/jcm10020289 ; PMCID: PMC7830623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Leong Bin Abdullah MFI, Ahmad Yusof H, Mohd Shariff N, Hami R, Nisman NF, Law KS. Depression and anxiety in the Malaysian urban population and their association with demographic characteristics, quality of life, and the emergence of the COVID-19 pandemic. Curr Psychol. 2021;40(12):6259–6270. doi: 10.1007/s12144-021-01492-2 Epub 2021 Feb 19. ; PMCID: PMC7892323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Yee A, Hodori N ‘Aqilah M, Tung YZ, Ooi PL, Latif SABA, Isa HM, et al. Depression level and coping responses toward the movement control order and its impact on quality of life in the Malaysian community during the COVID-19 pandemic: a web-based cross-sectional study. Ann Gen Psychiatry [Internet]. 2021;20(1):1–9. Available from: 10.1186/s12991-021-00352-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Al-Shannaq Y, Mohammad AA, Aldalaykeh M. Depression, coping skills, and quality of life among Jordanian adults during the initial outbreak of COVID-19 pandemic: cross sectional study. Heliyon. 2021. Apr 20;7(4):e06873. doi: 10.1016/j.heliyon.2021.e06873 ; PMCID: PMC8095109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Aruta JJBR, Callueng C, Antazo BG, Ballada CJA The mediating role of psychological distress on the link between socio-ecological factors and quality of life of Filipino adults during COVID-19 crisis. J Community Psychol. 2022. Mar;50(2):712–726. doi: 10.1002/jcop.22668 Epub 2021 Jul 14. ; PMCID: PMC8426953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Choi EPH, Hui BPH, Wan EYF, Kwok JYY, Tam THL, Wu C. COVID-19 and Health-Related Quality of Life: A Community-Based Online Survey in Hong Kong. Int J Environ Res Public Health. 2021. Mar 20;18(6):3228. doi: 10.3390/ijerph18063228 ; PMCID: PMC8003940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ferreira LN, Pereira LN, da Fé Brás M, Ilchuk K. Quality of life under the COVID-19 quarantine. Qual Life Res. 2021 May;30(5):1389–1405. doi: 10.1007/s11136-020-02724-x Epub 2021 Jan 2. ; PMCID: PMC7778495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Lipskaya-Velikovsky L. COVID-19 Isolation in Healthy Population in Israel: Challenges in Daily Life, Mental Health, Resilience, and Quality of Life. Int J Environ Res Public Health. 2021. Jan 23;18(3):999. doi: 10.3390/ijerph18030999 ; PMCID: PMC7908389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Iglesias-López E, García-Isidoro S, Castellanos-Sánchez VO. COVID-19 pandemic: pain, quality of life and impact on public health in the confinement in Spain. Ann Palliat Med. 2021. Apr;10(4):4338–4353. doi: 10.21037/apm-20-2514 Epub 2021 Apr 19. . [DOI] [PubMed] [Google Scholar]
  • 39.Vitorino LM, Yoshinari Júnior GH, Gonzaga G, Dias IF, Pereira JPL, Ribeiro IMG, et al. Factors associated with mental health and quality of life during the COVID-19 pandemic in Brazil. BJPsych Open. 2021. May 14;7(3):e103. doi: 10.1192/bjo.2021.62 ; PMCID: PMC8129679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Campbell D, Davison J. The Impact of COVID-19 on the Health-Related Quality of Life of Individuals Living in Scottish Communities with High Infection Rates. Eur J Environ Public Heal. 2022;6(1):em0099. 10.21601/ejeph/11502 [DOI] [Google Scholar]
  • 41.Hansel TC, Saltzman LY, Melton PA, Clark TL, Bordnick PS. COVID-19 behavioral health and quality of life. Sci Rep. 2022. Jan 19;12(1):961. doi: 10.1038/s41598-022-05042-z ; PMCID: PMC8770794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Mohsen S, El-Masry R, Ali OF, Abdel-Hady D. Quality of life during COVID-19 pandemic: a community-based study in Dakahlia governorate, Egypt. Glob Health Res Policy. 2022. May 19;7(1):15. doi: 10.1186/s41256-022-00246-2 ; PMCID: PMC9117117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.van Ballegooijen H, Goossens L, Bruin RH, Michels R, Krol M. Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands. BMC Health Serv Res. 2021. Mar 12;21(1):227. doi: 10.1186/s12913-021-06240-7 ; PMCID: PMC7953179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ahsan Khodami M, Hassan Seif M, Sadat Koochakzadeh R, Fathi R, Kaur H. Perceived stress, emotion regulation and quality of life during the Covid-19 outbreak: A multi-cultural online survey. Ann Med Psychol (Paris). 2022. Jun;180(6):514–518. doi: 10.1016/j.amp.2021.02.005 Epub 2021 Feb 15. ; PMCID: PMC7883744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Obradovic M, Lal A, Liedgens H. Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health Qual Life Outcomes. 2013. Jul 1;11:110. doi: 10.1186/1477-7525-11-110 ; PMCID: PMC3722016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Gil-Lacruz M, Cañete-Lairla M, Navarro J, Montaño-Espinoza R, Espinoza-Santander I, Osorio-Parraguez P. Validation of the WHOQOL-BREF Quality of Life Questionnaire in an Urban Sample of Older Adults in a Neighbourhood in Zaragoza (Spain). Healthcare (Basel). 2022. Nov 12;10(11):2272. doi: 10.3390/healthcare10112272 ; PMCID: PMC9690437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Huo T, Guo Y, Shenkman E, Muller K. Assessing the reliability of the short form 12 (SF-12) health survey in adults with mental health conditions: a report from the wellness incentive and navigation (WIN) study. Health Qual Life Outcomes. 2018. Feb 13;16(1):34. doi: 10.1186/s12955-018-0858-2 ; PMCID: PMC5811954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Eurofound. European quality of life survey 2016: Quality of life, quality of public services, and quality of society. [Internet]. 2017. 76 p. Available from: https://www.eurofound.europa.eu/publications/report/2017/fourth-european-quality-of-life-survey-overview-report [Google Scholar]
  • 49.Montazeri A, Harirchi AM, Shariati M, Garmaroudi G, Ebadi M, Fateh A. The 12-item General Health Questionnaire (GHQ-12): translation and validation study of the Iranian version. Health Qual Life Outcomes. 2003. Nov 13;1:66. doi: 10.1186/1477-7525-1-66 ; PMCID: PMC280704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Teotônio I, Hecht M, Castro LC, Gandolfi L, Pratesi R, Nakano EY, et al. Repercussion of COVID-19 Pandemic on Brazilians’ Quality of Life: A Nationwide Cross-Sectional Study. Int J Environ Res Public Health. 2020. Nov 18;17(22):8554. doi: 10.3390/ijerph17228554 ; PMCID: PMC7698925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Kim YJ, Cho MJ, Park S, Hong JP, Sohn JH, Bae JN,et al. The 12-item general health questionnaire as an effective mental health screening tool for general korean adult population. Psychiatry Investig. 2013 Dec;10(4):352–8. doi: 10.4306/pi.2013.10.4.352 Epub 2013 Dec 16. ; PMCID: PMC3902152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Nguyen HTT, Moir MP, Nguyen TX, Vu AP, Luong LH, Nguyen TN, et al. Health-related quality of life in elderly diabetic outpatients in Vietnam. Patient Prefer Adherence. 2018. Jul 27;12:1347–1354. doi: 10.2147/PPA.S162892 ; PMCID: PMC6067618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Vu HM, Dang AK, Tran TT, Vu GT, Truong NT, Nguyen CT, et al. Health-Related Quality of Life Profiles among Patients with Different Road Traffic Injuries in an Urban Setting of Vietnam. Int J Environ Res Public Health. 2019. Apr 24;16(8):1462. doi: 10.3390/ijerph16081462 ; PMCID: PMC6517995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Nguyen SH, Nguyen LH, Vu GT, Nguyen CT, Le THT, Tran BX, et al. Health-Related Quality of Life Impairment among Patients with Different Skin Diseases in Vietnam: A Cross-Sectional Study. Int J Environ Res Public Health. 2019. Jan 23;16(3):305. doi: 10.3390/ijerph16030305 ; PMCID: PMC6388287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Nguyen AT, Nguyen LH, Nguyen TX, Nguyen HTT, Nguyen TN, Pham HQ, et al. Frailty Prevalence and Association with Health-Related Quality of Life Impairment among Rural Community-Dwelling Older Adults in Vietnam. Int J Environ Res Public Health. 2019. Oct 12;16(20):3869. doi: 10.3390/ijerph16203869 ; PMCID: PMC6843267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Shah R, Ali FM, Nixon SJ, Ingram JR, Salek SM, Finlay AY. Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey. BMJ Open. 2021. May 25;11(5):e047680. doi: 10.1136/bmjopen-2020-047680 ; PMCID: PMC8154981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Bouza E, Arango C, Moreno C, Gracia D, Martín M, Pérez V, et al. Impact of the COVID-19 pandemic on the mental health of the general population and health care workers. Rev Esp Quimioter. 2023. Apr;36(2):125–143. doi: 10.37201/req/018.2023 Epub 2023 Feb 21. ; PMCID: PMC10066913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Mion G., Hamann P., Saleten M., Plaud B., Baillard C., Psychological impact of the COVID-19 pandemic and burnout severity in French residents: A national study. The European Journal of Psychiatry, Volume 35, Issue 3, 2021, 173–180, 10.1016/j.ejpsy.2021.03.005. [DOI] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002137.r001

Decision Letter 0

Anil Gumber

15 Jun 2023

PGPH-D-23-00668

Impact of COVID-19 on Health-Related Quality of Life in the General Population: A Systematic Review

PLOS Global Public Health

Dear Dr. Nshimirimana,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 30 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Anil Gumber, Ph.D.

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please identify your study as "systematic review and meta-analysis" in the title.

2. Please provide separate figure files in .tif or .eps format only and remove any figures embedded in your manuscript file. Please also ensure all files are under our size limit of 10MB.

For more information about figure files please see our guidelines:

https://journals.plos.org/globalpublichealth/s/figures 

https://journals.plos.org/globalpublichealth/s/figures#loc-file-requirement

3. We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list. 

Additional Editor Comments (if provided):

An Interesting topic is covered by the authors. The paper need thorough English Editing. Abstracts also need better organisation. Aims and objectives of the papers are not clearly highlighted. Methods section need further attention as authors didn't mention inclusion and exclusion criteria. I am really concerned about the measurement of "impact" of COVID on QoL. It seems hardly any paper computed QoL at two points in time (before and during/after COVID) to see changes in QoL scores and then make judgement about the impact of COVID. In my view it just collated information from some cross-sectional studies done before or after COVID. Thus the authors can't justify their title of impact of COVID on QoL by reviewing cross-sectional studies. Therefore authors need to re-write a section separately on those where before and after QoL scores were computed and shown changes in Mean QOL score at two points in time. Table 1 should also mention Change in Mean QoL. Scores in Table 2 are presented but without much explanation about low/high quality of papers. Authors need to mention reasons for including the low quality papers in the review. Discussion is written poorly. It just summarises findings and needs to focus also on changes in QoL as a result of COVID.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I have the following comments for the authors to address. I am happy to review this paper again.

1) The important finding for this study is " EuroQuality of Life-Five dimensions was 0.88

95% confidence interval [0.69-1.07]. ". It is important to guide authors how does 0.88 compare to other disorders. Please compare with the following conditions and discuss in the discussion so that readers know where it stands:

General population under COVID-19 (EuroQol-5D = 0.95) (Tran et al 2020),

patients suffering from diabetes (EuroQol-5D= 0.8) Nguyen Huong Thi Thu et al 2018),

human immunodeficiency virus (HIV) (EuroQol-5D = 0.8) (Tran et al 2018),

skin diseases (EuroQol-5D= 0.73) (Nguyen et al 2019),

respiratory diseases (EuroQol-5D= 0.66) (Ngo et al 2019),

dengue fever (EuroQol-5D= 0.66) (Tran et al 2018),

frail elderly (EuroQol-5D = 0.58) (Nguyen Anh Trung et al 2019)

elderly after fall injury (EuroQol-5D = 0.46) (Vu et al 2019)

fracture injuries (EuroQol-5D = 0.23) (Vu et al 2019).

References:

Tran BX, Nguyen HT, Le HT et al. Impact of COVID-19 on Economic Well-Being and Quality of Life of the Vietnamese During the National Social Distancing. Front Psychol. 2020 Sep 11;11:565153. doi: 10.3389/fpsyg.2020.565153. PMID: 33041928; PMCID: PMC7518066.

Nguyen, Huong Thi Thu et al. “Health-related quality of life in elderly diabetic outpatients in Vietnam.” Patient preference and adherence vol. 12 1347-1354. 27 Jul. 2018, doi:10.2147/PPA.S162892

Tran, Bach Xuan et al. “Depression and Quality of Life among Patients Living with HIV/AIDS in the Era of Universal Treatment Access in Vietnam.” International journal of environmental research and public health vol. 15,12 2888. 17 Dec. 2018, doi:10.3390/ijerph15122888

Nguyen, Sau Huu et al. “Health-Related Quality of Life Impairment among Patients with Different Skin Diseases in Vietnam: A Cross-Sectional Study.” International journal of environmental research and public health vol. 16,3 305. 23 Jan. 2019, doi:10.3390/ijerph16030305

Ngo, Chau Quy et al. “Effects of Different Comorbidities on Health-Related Quality of Life among Respiratory Patients in Vietnam.” Journal of clinical medicine vol. 8,2 214. 7 Feb. 2019, doi:10.3390/jcm8020214

Tran, Bach Xuan et al. “Cost-of-Illness and the Health-Related Quality of Life of Patients in the Dengue Fever Outbreak in Hanoi in 2017.” International journal of environmental research and public health vol. 15,6 1174. 5 Jun. 2018, doi:10.3390/ijerph15061174

Nguyen, Anh Trung et al. “Frailty Prevalence and Association with Health-Related Quality of Life Impairment among Rural Community-Dwelling Older Adults in Vietnam.” International journal of environmental research and public health vol. 16,20 3869. 12 Oct. 2019, doi:10.3390/ijerph16203869

Vu, Hai Minh et al. “Effects of Chronic Comorbidities on the Health-Related Quality of Life among Older Patients after Falls in Vietnamese Hospitals.” International journal of environmental research and public health vol. 16,19 3623. 27 Sep. 2019, doi:10.3390/ijerph16193623

Vu HM, Dang AK, Tran TT, et al Health-Related Quality of Life Profiles among Patients with Different Road Traffic Injuries in an Urban Setting of Vietnam. Int J Environ Res Public Health. 2019 Apr 24;16(8):1462. doi: 10.3390/ijerph16081462. PMID: 31022979; PMCID: PMC6517995

2) The authors should discuss the impact of COVID-19 on burnout, depression and anxiety in the introduction, that may affect quality of life. Please discuss the following findings:

Search PubMed for: Burnout is an important public health issue at times of the COVID-19 pandemic. Current measures which focus on work-based burnout have limitations in length and/or relevance. When stepping into the post-pandemic as a new Norm Era, the burnout scale for the general population is urgently needed to fill the gap. This study aimed to develop a COVID-19 Burnout Views Scale (COVID-19 BVS) to measure burnout views of the general public in a Chinese context and examine its psychometric properties.

A systematic review of COVID-19 on mental health

Search for PubMed: Relatively high rates of symptoms of anxiety (6.33% to 50.9%), depression (14.6% to 48.3%), post-traumatic stress disorder (7% to 53.8%), psychological distress (34.43% to 38%), and stress (8.1% to 81.9%) are reported in the general population during the COVID-19 pandemic in China, Spain, Italy, Iran, the US, Turkey, Nepal, and Denmark.

The impact of COVID-19 on three continents and its relationship with physical health:

Search for PubMed: The results showed that Poland and the Philippines were the two countries with the highest levels of anxiety, depression and stress; conversely, Vietnam had the lowest mean scores in these areas. Chain mediation model showed the need for health information, and the perceived impact of the pandemic were sequential mediators between physical symptoms resembling COVID-19 infection (predictor) and consequent mental health status (outcome).

3) Under the method, the authors stated "A random-effects model was fitted to the data." Please provide more information about random-effects model:

Tandom-effects model attempted to generalize findings beyond the included studies by assuming that the selected studies are random samples from a larger population (Cheung et al 2012).

Reference:

Cheung MW et al (2012) Conducting a meta-analysis: basics and good practices. Int J Rheum Dis. 2012 Apr;15(2):129-35. doi: 10.1111/j.1756-185X.2012.01712.x. Epub 2012 Feb 22. PMID: 22462415.

Reviewer #2: This contribution provides the results of a systematic review of papers published in English language on associations of quality of life with COVID -19, based on 25 studies retrieved from different countries. Methodologically, the search procedure and data analysis were done according to international quality standards, with a pre-published protocol and following PROSPERO criteria, assessing risk of bias and heterogeneity as well as study quality check. The different measurement tools are adequately described, and main study findings are enumerated in text and tables. There is no surprise that, overall, reduced quality of life is observed in association with COVID-19. In its current version, the manuscript suffers from several shortcomings listed here.

1. In Figure 1, 1.700.074 hits are reported from first search strategy. Although search terms include ‘quality of life’, authors report that this large primary number of titles was reduced to 546. Information on how this most substantial reduction was achieved is missing.

2. Background: At the end of this Introduction authors should state what exactly the aims of their review are. For instance, they could mention that they are interested in examining the consistency of findings across different measurement approaches, or to test risk of bias in this field of research, or to explore variations of quality of life according to sociodemographic variables etc.

3. Methods: On p. 9, information on measurements in different countries is given twice on the same page.

4. Results: In Table 1, in the arrow ‘mean quality of life’ percentage is given in several cases. Please explain. Moreover, information about means in different studíes cannot be interpreted without additional information on the scale range and some standard value in healthy, unaffected populations. In contrast to Table 1, information given in Table 2 is very useful and well done.

5. Discussion: The section on study limitations needs critical extension. The relatively poor study quality (mainly cross-sectional!) needs to be emphasised. Authors should also make clear how data on comparisons of quality of life before and during pandemic were recorded in the frame of cross-sectional studies (Ref: 19, 22, 40, 41).

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Johannes Siegrist

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

<quillbot-extension-portal></quillbot-extension-portal><quillbot-extension-portal></quillbot-extension-portal>

Attachment

Submitted filename: PGPH-D-23-00668_AnilEdit.pdf

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002137.r003

Decision Letter 1

Anil Gumber

4 Oct 2023

Impact of COVID-19 on Health-Related Quality of Life in the General Population: A Systematic Review and Meta-analysis

PGPH-D-23-00668R1

Dear Dr Nshimirimana,

We are pleased to inform you that your manuscript 'Impact of COVID-19 on Health-Related Quality of Life in the General Population: A Systematic Review and Meta-analysis' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Anil Gumber, Ph.D.

Academic Editor

PLOS Global Public Health

***********************************************************

thanks for incorporating reviewers suggestions.

Reviewer Comments (if any, and for reference):

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PRISMA checklist.

    (DOC)

    S1 Table. Summary of included studies.

    (DOCX)

    S1 Text. PubMed search string.

    (DOCX)

    Attachment

    Submitted filename: PGPH-D-23-00668_AnilEdit.pdf

    Attachment

    Submitted filename: Response to Editor and reviewers.docx

    Data Availability Statement

    A protocol was registered in the international Prospective Register of Systematic Reviews database (PROSPERO) registration number (CRD42021269897).


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES